Molecular Therapeutics

Type: Company
Name: Molecular Therapeutics
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Do animals have a sense of humor?

Right now, in a high-security research lab at Northwestern University’s Falk Center for Molecular Therapeutics, scientists are tickling rats. Their goal? To develop a pharmaceutical-grade happiness pill.But their efforts might also produce some of the ... [Published Minneapolis Star Tribune - 18 hours ago]
First reported Apr 21 2014 - Updated Apr 22 2014 - 1 reports

HERS Breast Cancer Foundation Event Honors Community Leadership in...

The fifth annual People with Purpose Awards Luncheon on April 24 recognizes the contributions of local nonprofits, business leaders, and doctors in support of breast cancer survivors. HERS Breast Cancer Foundation today announced that they are hosting ... [Published PRWeb - Apr 21 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

UGA BioBusiness Center helps turn discoveries into companies

The University of Georgia unleashes thousands of graduates each year into the business world, but one modest building tucked away on the edge of campus aims to produces businesses.The Georgia BioBusiness Center’s primary aim is to give a leg up to UGA ... [Published OnlineAthens - Apr 19 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Bayer to Present New Data on Advancing Oncology Portfolio

– Bayer HealthCare (Bayer) will present latest preclinical and clinical data on promising early-stage compounds with new mechanism of action at the American Association for Cancer Research (AACR) 105th Annual Meeting, April 5-9, 2014, in San Diego, C ... [Published Bayer Schering Pharma - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Do animals have a sense of humor?

Right now, in a high-security research lab at Northwestern University's Falk Center for Molecular Therapeutics, scientists are tickling rats. Their goal? To develop a pharmaceutical-grade happiness pill. But their efforts might also produce some of the ... [Published The Land - Apr 03 2014]
First reported Apr 02 2014 - Updated Apr 03 2014 - 2 reports

Rexahn to Present Poster on RX-21101 Nano-Polymer-Drug Conjugate Systems at AACR Meeting

Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that it will have two poster presentations at the 2014 American Association for Cancer Research ... [Published Azonano - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Gene Therapy Expert to Join The Children's Hospital of Philadelphia

Dr. Beverly Davidson researches novel treatments for neurological diseases Contact InformationAvailable for logged-in reporters onlyNewswise — Philadelphia, April 1, 2014 –Beverly L. Davidson, Ph.D., a nationally prominent expert in gene therapy, is ... [Published Newswise - Apr 01 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 2 reports

CBL0137 Combination Studies to Be Presented at 2014 AACR Annual Meeting

BUFFALO, NY -- (Marketwired) -- 04/01/14 -- Cleveland BioLabs, Inc.(NASDAQ:CBLI) announced two upcoming poster presentations at the 2014 American Association for Cancer Research (AACR) Annual Meeting, April 5-9, 2014 in San Diego, CA.The posters, titled ... [Published Nasdaq - Apr 01 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Aeterna Zentaris to Present Poster on New Therapeutic Opportunities in Oncology with Erk Inhibitors at AACR Meeting in San Diego

/PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that a poster will be presented on AEZS-134, a highly potent and selective ATP competitive Erk inhibitor, during the American Association for Cancer Research ... [Published I Stock Analyst - Apr 01 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 2 reports

Do animals have a sense of humor?

Right now, in a high-security research lab at Northwestern University's Falk Center for Molecular Therapeutics, scientists are tickling rats. Their goal? To develop a pharmaceutical-grade happiness pill. But their efforts might also produce some of the ... [Published Kokomo Tribune - Mar 28 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

OXiGENE Announces Presentation of Three Preclinical Abstracts at 2014 AACR Conference

(GLOBE NEWSWIRE) -- OXiGENE, Inc. ( OXGN ), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, today announced that data from three studies related to its early stage scientific programs will be presented at the ... [Published Yahoo! Finance - Mar 27 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 2 reports

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014

(GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced new data from three research programs which support its investigational lead compound ... [Published Virtual Strategy Magazine - Mar 26 2014]

Quotes

...Dr. Allison is a breast cancer survivor and author of "Red Sunshine: A Story of Strength and Inspiration from a Doctor Who Survived Stage 3 Breast Cancer."
The first poster entitled, "A novel small molecule cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to treatment with gemcitabine" will be presented on Sunday, April 6, 2014, during the "Experimental and Molecular Therapeutics 6" poster session from 1:00 pm - 5:00 pm in Hall A-E...
- "Detection of EGFR, HER2, HER3 and HER4 Hetero- and Homodimerization Using EFC-based Cellular Assays" Location: Hall A-E, Poster Section 32 (Experimental and Molecular Therapeutics 27)Date & Time: Tuesday April 8, 2014, 8:00 AM - 12:00 PM
The posters, titled "Synergistic effects of CBL0137 and gemcitabine against non-small cell lung and pancreatic cancer xenografts" and "CBL0137 demonstrates significant antitumor activity against hepatocellular carcinoma alone and in combination with sorafenib" will be presented on Sunday, April 6, during the Experimental and Molecular Therapeutics sessions 5 and 6, respectively...

More Content

All (29) | News (27) | Reports (0) | Blogs (1) | Audio/Video (1) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Do animals have a sense of humor? [Published Minneapolis Star Tribune - 18 hours ago]
HERS Breast Cancer Foundation Event Honors Comm... [Published PRWeb - Apr 21 2014]
UGA BioBusiness Center helps turn discoveries i... [Published OnlineAthens - Apr 19 2014]
Rexahn Pharmaceuticals to Present Data on RX-31... [Published Pharmacy Choice - Apr 16 2014]
Rexahn Pharmaceuticals to Present Data on RX-31... [Published HispanicBusiness.com - Apr 10 2014]
Bayer to Present New Data on Advancing Oncology... [Published Bayer Schering Pharma - Apr 04 2014]
DiscoveRx Platforms for Phenotypic and Target B... [Published PredictWallStreet - Apr 04 2014]
Do animals have a sense of humor? [Published The Land - Apr 03 2014]
Rexahn to Present Poster on RX-21101 Nano-Polym... [Published Azonano - Apr 03 2014]
Rexahn Pharmaceuticals to Present Data on RX-31... [Published Investor's Business Daily - Apr 02 2014]
Gene Therapy Expert to Join The Children's Hosp... [Published Newswise - Apr 01 2014]
CBL0137 Combination Studies to Be Presented at ... [Published Nasdaq - Apr 01 2014]
CLEVELAND BIOLABS : CBL0137 Combination Studies... [Published 4 Traders - Apr 01 2014]
Aeterna Zentaris to Present Poster on New Thera... [Published I Stock Analyst - Apr 01 2014]
Stemline Therapeutics Announces Presentation of... [Published Yahoo! Finance - Apr 01 2014]
MERRIMACK PHARMACEUTICALS : to Present at the 2... [Published 4 Traders - Mar 31 2014]
Do animals have a sense of humor? [Published Kokomo Tribune - Mar 28 2014]
Do animals have a sense of humour? [Published New Scientist - Mar 28 2014]
TetraLogic Pharmaceuticals to Present Data From... [Published Reuters - Mar 27 2014]
OXiGENE Announces Presentation of Three Preclin... [Published Yahoo! Finance - Mar 27 2014]
The Humor Code [Published Slate Magazine - Mar 27 2014]
Hospitality industry a key battleground [Published Irish Medical Times - Mar 26 2014]
Arno Therapeutics to Present Three New Studies ... [Published Virtual Strategy Magazine - Mar 26 2014]
ARNO THERAPEUTICS : to Present Three New Studie... [Published 4 Traders - Mar 26 2014]
Hypocretin (orexin), dynorphin, and reward [Neu... [Published PNAS - Mar 25 2014]
Spark Therapeutics and Genable Technologies Ann... [Published Reuters - Mar 25 2014]
Antibody could be used to target tumor-causing ... [Published Pharmacy Choice - Mar 24 2014]
Forbion Capital-backed uniQure completes IPO [Published PE Hub Blog - Feb 13 2014]
Paul J. Kenny, PhD, Named Chair of Pharmacology... [Published PRWeb - Oct 11 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Forbion Capital-backed uniQure completes IPO [Published PE Hub Blog - Feb 13 2014]
Forbion Capital Partners -backed uniQure , which develops gene therapy products, has completed an initial public offering at a price of $17 per share on the NASDAQ . Jefferies and Leerink Partners acted as joint book-running managers and Piper ...
1

Audio/Video

sort by: Date | Relevance
The Humor Code [Published Slate Magazine - Mar 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.